ARCH Venture Partners β 2022 Investments
8 investments dated 2022 Β· listed companies and verified rows first Β· show all
Brooklyn, US
Zen Chu(Director)Lis Rhodes(Executive Officer)Francois Kress(Executive Officer, Director)
BoardAdam D'Augelli(Director)
Board seatRobert NelsenΒ· per SEC Form D Β· $10M raise Β· filed Mar 2022
BiotechSeattle, US
Thomas King(Director)Brian Blackman(Executive Officer)Simon Tulloch(Executive Officer)Steven Gillis(Executive Officer, Director, Promoter)Mark Roth(Executive Officer, Director, Promoter)Stephen Hill(Executive Officer, Director)
Board seatSteven GillisΒ· per SEC Form D
AgTechVolga, US
Mark Hyde(Executive Officer)Gary Goplen(Director)Spencer Enninga(Director)Lewis Bainbridge(Director)Thomas J Kersting(Executive Officer)Mark Mickelson(Director)
Board seatRobert NelsenΒ· per SEC Form D Β· $230M raise Β· filed Oct 2022
IngredientWerks is a molecular farming company that engineers crops to produce animal-identical proteins as plant-based ingredients for the alternative protein food market.
AgTechBiotechFoodTechWoburn, US
Steve Snyder(Director)Clinton Bybee(Director)Ronald Warner Meeusen(Director)James Schultz(Director)Matthew Plavan(Executive Officer, Director)
Board seatClinton BybeeΒ· per SEC Form D Β· $5M raise Β· filed Aug 2022
BiotechCambridge, US
Giampiero De Luca(Director)Jodi A. Cook(Executive Officer, Director)Will McLean(Executive Officer)
Board seatSteve GillisΒ· per SEC Form D
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in
BoardSean Kendall(Director)Malek Faham(Director)
Recuro is a virtual-first digital health platform that provides primary care, behavioral health, urgent care, and supplemental benefits (pharmacy, care management, advocacy) to patients, employers, health plans, and providers.
Digital HealthHealthtechSaaSRichardson, US
Michael Brombach(Chief Executive Officer and Co-Founder)Dr. Kate Sowerwine(Chief Medical Officer)John Halsey(Director)Michael Moradi(Director)Michael Gorton(Chief Executive Officer)Kris Engskov(Director)
Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.
BiotechDeep TechMedical DevicesCampbell, US
Thomas James Oxley(Executive Officer, Director)Martin Dieck(Director)Nicholas Opie(Director)Rahul Sharma(Director)
BoardAlex Morgan(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.